Is Evelo Biosciences Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Evelo Biosciences Inc (EVLO) is currently classified as NOT HALAL as of November 2023. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Evelo Biosciences Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Evelo Biosciences Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Evelo Biosciences Inc?

Muslim investors may consider investing in Evelo Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Evelo Biosciences Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Evelo Biosciences Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Evelo Biosciences Inc updated?

The Shariah compliance status of Evelo Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Evelo Biosciences Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Evelo Biosciences Inc?

You can check the latest Shariah compliance status of Evelo Biosciences Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EVLO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 20, 2023

Report Source: 2023 3rd Quarter Report

Evelo Biosciences Inc. Stock Analysis EVLO

United States Health Care Nano Cap Report: Q3, 2023

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. The company is headquartered in Foxboro, Massachusetts and currently employs 66 full-time employees. The company went IPO on 2018-05-09. The firm is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. Its small intestinal axis (SINTAX) is the network of connections that links the small intestine and the rest of the body. Immune cells and other cells in the small intestine act as sentinels and are constantly sensing the contents of the gut. Depending on what is sensed, these cells relay messages from the gut to the rest of the body that modulate systemic immunity. Its orally delivered product candidates are pharmaceutical compositions of specific single strains of commensal microbes or the extracellular vesicles (EVs) they shed.

Key Statistics of Evelo Biosciences Inc (EVLO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

333.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

4745.70

Avg. Volume

2392.88

Dividend Yield

Financial Metrics & Statements of Evelo Biosciences Inc (EVLO)

FAQ's for Evelo Biosciences Inc (EVLO)

According to Musaffa’s Shariah screening methodology, Evelo Biosciences Inc (EVLO) is currently classified as NOT HALAL as of November 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.